Phase II study of vismodegib in patients with SMO or PTCH1 mutated tumors: Results from NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol T Meeting Abstract
| Authors: | Tsao, A. S.; Song, Z.; Ho, A. L.; Mehnert, J. M.; Mitchell, E. P.; Wright, J. J.; Takebe, N.; Gray, R. J.; Wang, V.; McShane, L.; Rubinstein, L. V.; Patton, D. R.; Williams, P. M.; Hamilton, S. R.; Conley, B. A.; Arteaga, C. L.; Harris, L.; O'Dwyer, P. J.; Chen, A. P.; Flaherty, K. |
| Abstract Title: | Phase II study of vismodegib in patients with SMO or PTCH1 mutated tumors: Results from NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol T |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300903 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.3010 |
| Notes: | Meeting Abstract: 3010 -- Meeting also held virtually -- Source: Wos |
